VBI Vaccines - 26 Year Stock Price History | VBIV

Historical daily share price chart and data for VBI Vaccines since 1995 adjusted for splits. The latest closing stock price for VBI Vaccines as of September 27, 2021 is 3.41.
  • The all-time high VBI Vaccines stock closing price was 91.68 on August 02, 2005.
  • The VBI Vaccines 52-week high stock price is 4.83, which is 41.6% above the current share price.
  • The VBI Vaccines 52-week low stock price is 2.07, which is 39.3% below the current share price.
  • The average VBI Vaccines stock price for the last 52 weeks is 3.16.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
VBI Vaccines Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 3.2653 2.9300 4.3200 2.6100 3.4100 24.00%
2020 2.4762 1.3400 6.1700 0.7250 2.7500 99.28%
2019 1.2509 1.6500 2.1200 0.4712 1.3800 -13.75%
2018 2.7983 4.4700 4.4700 1.2200 1.6000 -62.53%
2017 4.2770 3.2600 6.4600 3.1500 4.2700 37.74%
2016 3.8547 4.6200 5.0998 2.1000 3.1000 -36.48%
2015 5.4265 6.5540 6.5540 4.5400 4.8800 -26.73%
2014 7.8698 10.1000 12.7000 4.0400 6.6600 -34.06%
2013 9.5674 8.2000 17.9000 6.1000 10.1000 26.25%
2012 8.9909 6.0000 13.5000 5.6000 8.0000 50.94%
2011 10.1249 10.2000 13.0000 5.1000 5.3000 -51.38%
2010 13.1983 15.0000 16.2000 8.8000 10.9000 -31.45%
2009 13.5273 10.8000 25.1000 8.0000 15.9000 52.88%
2008 36.6861 48.7000 55.2000 10.0000 10.4000 -78.33%
2007 50.8385 50.6000 60.5000 43.5000 48.0000 -7.69%
2006 62.3355 60.0000 86.1000 47.8000 52.0000 -13.12%
2005 53.0885 41.5050 91.6800 38.2500 59.8500 44.22%
2004 40.1064 50.0000 76.5000 26.1000 41.5000 -9.49%
2003 28.4316 23.2500 52.3500 20.1000 45.8500 97.20%
2002 30.5246 35.5000 41.1500 23.0550 23.2500 -31.11%
2001 26.0372 25.7800 33.7500 20.6250 33.7500 30.92%
2000 34.6685 26.2500 45.0000 25.3000 25.7800 -4.16%
1999 21.8001 13.1250 27.5000 13.1250 26.9000 38.84%
1998 19.0222 25.6250 33.7500 10.0000 19.3750 -26.19%
1997 19.6668 13.7500 33.1250 12.8150 26.2500 90.91%
1996 10.4947 5.0000 17.5000 4.3750 13.7500 175.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.873B $0.001B
VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company's eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus vaccine. Its second platform is a thermostable technology that enables the development of vaccines and biologics. VBI Vaccines Inc., formerly known as SciVac Therapeutics, Inc., is headquartered in Cambridge, MA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29